- $3.15bn
- $4.13bn
- $2.23bn
Annual cashflow statement for ICU Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 103 | -74.3 | -29.7 | -118 | 0.732 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 59.7 | 80.7 | 103 | 105 | 68.4 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 14.2 | -237 | -53.2 | -28.8 | -65.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | 268 | -62.1 | 166 | 204 | 180 |
| Capital Expenditures | -81.2 | -99.3 | -93.7 | -90.2 | -97 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -9.52 | -1,810 | 5.72 | 1.25 | 219 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -90.7 | -1,909 | -87.9 | -89 | 122 |
| Financing Cash Flow Items | -25.6 | -13.1 | -9.35 | -14.6 | -13.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -16.9 | 1,637 | -36 | -55.8 | -312 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 157 | -344 | 45.4 | 54.3 | -0.603 |